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Abstract
Non-enveloped viruses must deliver their viral genome across a cell membrane without the advantage of membrane fusion.
The mechanisms used to achieve this remain poorly understood. Human rhinovirus, a frequent cause of the common cold,
is a non-enveloped virus of the picornavirus family, which includes other significant pathogens such as poliovirus and foot-
and-mouth disease virus. During picornavirus cell entry, the small myristoylated capsid protein VP4 is released from the
virus, interacts with the cell membrane and is implicated in the delivery of the viral RNA genome into the cytoplasm to
initiate replication. In this study, we have produced recombinant C-terminal histidine-tagged human rhinovirus VP4 and
shown it can induce membrane permeability in liposome model membranes. Dextran size-exclusion studies, chemical
crosslinking and electron microscopy demonstrated that VP4 forms a multimeric membrane pore, with a channel size
consistent with transfer of the single-stranded RNA genome. The membrane permeability induced by recombinant VP4 was
influenced by pH and was comparable to permeability induced by infectious virions. These findings present a molecular
mechanism for the involvement of VP4 in cell entry and provide a model system which will facilitate exploration of VP4 as a
novel antiviral target for the picornavirus family.
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Introduction
A fundamental step in the process of viral infection is the
delivery of the virus genome across the hydrophobic barrier of the
host cell membrane. Enveloped viruses achieve this through the
fusion of viral and target-cell membranes [1,2]. However, non-
enveloped viruses must employ alternative mechanisms to deliver
their genomes into cells, such as membrane disruption or pore
formation. Cell-entry studies with diverse families of non-
enveloped viruses have increased our understanding of these
processes and revealed common themes in the mechanisms used
for membrane penetration, for example priming of virus particles
by proteolytic processing and the exposure, multimerization and
membrane interaction of hydrophobic or N-myristoylated viral
proteins reviewed in [3,4].
Human rhinovirus (HRV) is a small non-enveloped RNA virus
belonging to the enterovirus genus of the picornavirus family, and
is the most frequent cause of mild respiratory tract infections (the
common cold) [5]. In recent years, it has been recognized that
HRV infection is also associated with more serious clinical
outcomes such as severe lower respiratory tract infections of
infants and exacerbations of chronic lung diseases (asthma, cystic
fibrosis and chronic obstructive pulmonary disease) reviewed in
[6,7]. Despite decades of research there is still no vaccine or
licensed drug to prevent or reduce infection by HRV. The
picornavirus family includes many other significant pathogens
such as poliovirus (PV), enterovirus 71 (EV71), hepatitis A virus
(HAV) and foot-and-mouth disease virus (FMDV), for which new
or improved measures for disease control are also required.
The picornavirus particle comprises a molecule of single-
stranded positive-sense RNA within a capsid of approximately
30 nm diameter. The capsid contains 60 copies of each of 4
structural proteins, VP1, VP2, VP3 and VP4, arranged with T=1
(pseudo T=3) icosahedral symmetry. The VP4 protein is small
(predicted molecular weight of HRV VP4 approximately
7.5 kDa), hydrophobic, myristoylated at its N-terminus (post-
translationally modified by the attachment of the 14-carbon
saturated fatty acid, myristic acid [8]) and is located on the inside
surface of the virus capsid.
Experimental data from cell culture, biochemical and structural
studies have led to a proposed mechanism for entry by HRV and
PV (and other closely related picornaviruses) [9–11] in which a
‘trigger’ that can be receptor binding and/or low pH (depending
on the virus) induces major conformational changes in the virus
capsid. The resulting ‘altered’ (A) particle interacts with mem-
branes and releases the viral RNA into the cytoplasm via an
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formed in the membrane by VP4 and/or the N-terminal region of
the VP1 protein. VP4 and the N-terminal region of VP1 are
internal components of the mature virus but become externalised
during conformational changes that result in the generation of the
cell entry intermediate A particle. The A particle interacts directly
with membranes without further involvement of the cellular virus
receptor [12,13]. VP1 acts to tether the particle to the membrane
[12,13] and mutagenesis of VP4 has demonstrated its involvement
in both virus induced permeability in model membranes [14] and
genome delivery during infection of cells [14,15]. The interaction
between virus and model membranes has recently been shown to
involve an ‘umbilicus’ connecting the capsid and membrane,
presumably as part of the mechanism for delivery of viral RNA
across the membrane [16]. The selective release of dextrans from
endosomes during infection of cells has provided evidence that
membrane permeability involves formation of a pore [17] but the
mechanism of pore formation remains unknown. We previously
demonstrated that recombinant VP4 as a GST fusion protein was
able to induce permeability in model membranes [18]. In the
present study, we have produced recombinant VP4 with a
minimal tag and shown that VP4 induced membrane permeability
is mediated by the formation of a homo-multimeric, size-selective
membrane pore.
Results
Recombinant VP4
Previous studies have implicated picornavirus VP4 in viral
penetration of the cell membrane and virus induced permeability
in model membranes [13,14,19]. To further investigate the
function of VP4 using biophysical approaches it was necessary to
work with isolated protein. Although native VP4 can be isolated
from purified virus, the amount of the protein derived from
laboratory-scale virus preparations was insufficient for biophysical
studies. To address this problem we previously produced
recombinant HRV16 VP4 as an N-terminally myristoylated
VP4GST fusion protein (VP4GST) which was able to induce
membrane permeability in model membranes [18]. In the present
study, the same bacterial expression system was used to produce
myristoylated VP4 with a smaller tag (six-histidines at the C-
terminus of VP4; VP4His). VP4His was overexpressed as insoluble
inclusion bodies, purified by denaturing nickel affinity chroma-
tography, precipitated and solubilised in DMSO, with a final yield
of purified protein in the order of 0.1–0.5 mg per litre of culture.
Protein purity was assessed by SDS-PAGE and silver staining and
the concentration of recombinant VP4 was confirmed by
comparison with native VP4 present in known quantities in
purified HRV16 (Fig. 1). The migration of native VP4 and
recombinant VP4His was consistent with their predicted molec-
ular weights (approximately 7.4 kDa and 8.2 kDa respectively).
Recombinant VP4His induces membrane permeability
The ability of VP4His to induce permeability in model
membranes was investigated by mixing purified recombinant
Figure 1. Purity and concentration of recombinant VP4
assessed by SDS-PAGE. Concentration of purified VP4His estimated
by protein assay was confirmed by comparison with known quantities
of native VP4 in preparations of purified virus. HRV16 (3 or 1 mg,
equivalent to 0.15 or 0.05 mg VP4 respectively) and VP4His at amounts
indicated, were subjected to SDS-PAGE and visualized by silver staining
(A) or western blot using antisera to VP4 (B). Molecular mass markers
(in kilodaltons) are indicated on the left. Arrows show expected position
of the indicated viral proteins. The migration of VP4His appears slower
with increasing concentration as a result of the increasing concentra-
tion of DMSO in these samples. The migration of VP4His was not altered
when diluted in a constant concentration of DMSO (figure S1).
doi:10.1371/journal.ppat.1004294.g001
Author Summary
Human rhinovirus (HRV) is a non-enveloped virus of the
picornavirus family and is responsible for respiratory
infections (common colds) costing billions of dollars ($)
annually. There remains no vaccine or licensed drug to
prevent or reduce infection. Related members of the
picornavirus family include significant pathogens such as
poliovirus, enterovirus 71 and foot-and-mouth disease
virus, for which improved control measures are also
required. A fundamental step in virus infection is the
delivery of the viral genetic material through the barrier of
the cellular membrane. Viruses such as HIV and influenza
are enveloped in an outer membrane which can fuse with
the host cell membrane to allow the viral genome to
penetrate into the cytoplasm. However, non-enveloped
viruses such as picornaviruses lack a membrane and the
mechanisms for penetration of the membrane by these
viruses remain poorly understood. The capsid protein VP4
has previously been implicated in the delivery of the
picornavirus genome. In this study we demonstrate that
HRV VP4 interacts with membranes to make them
permeable by the formation of multimeric, size-selective
membrane pores with properties consistent with the
transport of viral genome through the membrane. This
function of VP4 provides a novel antiviral target for this
family of viruses.
Picornavirus VP4 Forms a Membrane Pore
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neutral pH and room temperature, and detecting the VP4-
induced release of encapsulated dye. VP4His induced a robust
signal for membrane permeability and both rate and extent of dye-
release were dose-dependent (Fig. 2).
VP4His-induced membrane permeability is
myristoylation and pH dependent
For many picornaviruses, endosomal protonation triggers
particle alterations involved in uncoating and membrane pene-
tration. Different HRVs exhibit a range of sensitivities to pH
mediated uncoating, depending on serotype and receptor usage.
For example, uncoating of the minor group HRV2 is entirely
dependent on low pH in late endosomes [20] while for the major
group HRV14, receptor interactions also contribute to triggering
particle alterations and this virus is therefore able to uncoat at the
less acidic pH found in early endosomes [21]. In order to
investigate the effect of pH on the function of VP4 we compared
liposome dye-release assays at neutral pH and acidic pH values
representing early (pH 6.5) and late (pH 5.5) endosomes [22].
Carboxyfluorescein (CF) fluorescence is quenched at low pH
(Fig. S2) therefore the dye-release assay was first modified to allow
the comparison of data collected at different pH values. End point
data from dye-release assays can be expressed as a proportion of
the total signal released by disruption of liposomes with detergent.
End point samples can also be normalised for pH by separating
the released fluorescence (by pelleting the liposomes) and adjusting
to the same detergent and pH conditions as the detergent-released
control. However, we wished to compare the kinetics of dye-
release (not just end points) and therefore required an alternative
procedure for normalising real-time CF dye-release assays carried
out at different pH values.
We therefore used the well-characterised pH independent pore-
forming peptide melittin [23,24] as a control for the liposome dye-
release assay. The permeability induced by melittin appeared
reduced at low pH due to the quenching of CF fluorescence at low
pH (Fig. 3A). However, when samples were separated from
liposomes and adjusted to neutral pH as described above, the
signal in all samples became equivalent to the pH 7.0 sample. This
confirmed that melittin induced permeability was indeed pH
independent and that dye-release data generated at a given pH
could be expressed as a proportion of the maximum release by a
melittin control at that same pH. This provided a method for
normalisation of data which corrected for the low-pH quenching
of CF and allowed real-time data generated at different pH values
to be directly compared.
The pore-forming peptide GALA, which only forms pores in
model membranes at pH,6 [25,26] was used as an additional
control. As expected GALA did not induce permeability at pH 7.0
or pH 6.5 but induced robust permeability at pH 5.5 (Fig. 3B).
Native VP4 is myristoylated at the N-terminus. The effect of the
myristate group on the induction of membrane permeability by
VP4His was therefore determined by comparing myristoylated
(VP4His) and unmyristoylated (DVP4His) forms of recombinant
protein in the liposome dye-release assay. Both forms of VP4
induced membrane permeability but VP4His (myristoylated)
generally induced more extensive membrane permeability with a
higher initial rate of release than DVP4His (unmyristoylated)
(Fig. 3C & D). The permeability induced by both VP4His and
DVP4His increased at more acidic pH values (Fig. 3C, D, E).
However, VP4His consistently induced more extensive perme-
ability than DVP4His at all pH values tested (Fig. 3E). Analysis of
the dye-release kinetics showed that the initial rate of release
induced by VP4His increased dramatically with decreasing pH,
but the corresponding effect was not seen with DVP4His (Fig. 3F).
No significant permeability was seen in control samples exposed
to low pH conditions in the absence of protein/peptide. Together
these findings suggest that VP4 membrane interactions are more
efficient at low pH and that the presence of myristate is required
for maximum membrane activity of VP4 under the physiological
conditions encountered during HRV entry.
VP4-induced membrane permeability is size-selective
We hypothesised that VP4-induced membrane permeability
was the result of formation of discrete pores with dimensions
sufficient for transfer of macro-molecules such as RNA across the
membrane. This was investigated by measuring the VP4-induced
release from liposomes of FITC-labelled dextrans of different sizes.
Smaller dextrans of 4 kDa (Stokes’ radius of 14 A ˚) and 10 kDa
(Stokes’ radius of 23 A ˚) were indeed released from liposomes with
higher efficiency than 70 kDa (Stokes’ radius of 60 A ˚) and
250 kDa (Fig. 4A). The pore forming toxin melittin was included
as a control for these studies and released only the smallest dextran
tested (Fig. 4B), in agreement with previous reports [24,27]. These
experiments indicate that VP4 permeability is via formation of
size-selective membrane pores which limit the transfer of
molecules with Stokes’ radius approaching ,60 A ˚. Such a pore,
with a lumen diameter #12 nm would be consistent with the size
required for passage of single-stranded nucleic acid.
VP4 multimerizes to form a pore structure
Membrane pores formed by small pore-forming proteins or
peptides often have a homo-oligomeric structure. Multimerization
seemed the likely mechanism for VP4 pore formation. We
therefore investigated the ability of VP4 to form a homomulti-
meric complex by analysing samples by PAGE. Purified VP4His
was difficult to detect when analysed directly by native PAGE
(non-denaturing conditions) and silver staining (Fig. 5A) perhaps
due to solubility or charge which did not permit efficient
electrophoresis. However, after mixing with liposome membranes
or the membrane mimetic detergent DHPC, VP4 appeared to be
readily detected (Fig. 5A), suggesting that interaction with micelles
or multimerization was able to facilitate migration into the gel.
Figure 2. Recombinant VP4 induces dose-dependent mem-
brane permeability. Liposomes containing carboxyfluorescein (CF) at
self-quenching concentration, were mixed with VP4His at the indicated
final concentrations. Membrane permeability resulting in leakage and
dequenching of CF was detected by fluorescence measurements
(excitation 492 nm/emission 512 nm) recorded every 30 seconds. Data
shown is representative of multiple experiments (n.3). The end point
fluorescent signal induced by 5000 nM VP4His was equivalent to 70–
80% of the total release induced by addition of 0.5% Triton X-100.
doi:10.1371/journal.ppat.1004294.g002
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liposomes at pH 7.0, pH 6.5, and pH 5.5, were mixed with the following peptides or proteins and membrane permeability resulting in leakage and
dequenching of CF was detected by fluorescence measurements (excitation 492 nm/emission 512 nm) recorded every 30 seconds. A) The pH-
independent pore-forming peptide melittin at 10 mM. AU, arbitrary units. CF fluorescence is known to be less efficient at low pH and the apparent
reduction in melittin-induced signal at low pH values (pH 6.5 and pH 5.5) could therefore be restored to the same level as the pH 7 sample by
adjusting released CF in supernatants to neutral pH (data not shown), thus confirming that melittin-induced permeability was unaffected by pH and
demonstrating a requirement to compensate for the reduced efficiency of CF fluorescence at low pH. Therefore, data in the remaining panels (B–F)
was normalized to the maximum signal induced by melittin at each pH value. B) the acid-dependent pore-forming peptide GALA at 1 mM. C) VP4His
at 5 mM. D) DVP4His (unmyristoylated) at 5 mM. E) End point and F) initial rates are shown to summarise the data in panels A–D. Data shown is
representative of multiple experiments (n.3). Error bars represent standard error of the mean of values from 3 experiments.
doi:10.1371/journal.ppat.1004294.g003
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detected by SDS-PAGE (see Fig. 1). Samples of VP4His in the
presence of liposomes were therefore treated with the amine-
reactive chemical cross-linker dithiobis (succinimidyl propionate)
(DSP), separated by SDS-PAGE and identified by western blot.
Crosslinking in the presence of liposomes resulted in detection of a
characteristic ladder of bands, corresponding in size to monomeric
VP4His (predicted size of approximately 8.2 kDa) and cross-linked
multimers of VP4His in increasing numbers, up to a hexameric
complex migrating with apparent molecular weight of approxi-
mately 50 kDa (Fig. 5B, lanes 6 and 7). The presence of species
with uniform and incremental increases in apparent molecular
weight equivalent to the addition of VP4His monomers, suggested
multimerization of monomeric species rather than random
aggregation. Upon reversing the crosslinking with DTT, the
presence of multimers was diminished and an increase in
monomer was observed (Fig. 5B, lane 8), implying that the
multimeric units were indeed comprised of VP4His monomers.
Interestingly, VP4His multimerization was also detected in the
absence of crosslinking; in these samples a band equivalent to the
dimeric and hexameric complexes were clearly seen but interme-
diate multimers were of reduced intensity (Fig. 5B, lane 5), similar
to the appearance of samples after reversal of crosslinking. This
suggested that the putative hexameric structure was more stable
Figure 4. VP4-induced permeability is size-selective. Liposomes containing FITC-labelled dextrans of 4 kD (FD4), 10 kD (FD10), 70 kD (FD70) or
250 kD (FD250) were mixed with 5 mM VP4His (A)o r1 0mM melittin (B). Release of dextrans was quantified by pelleting the liposomes and measuring
the fluorescence in the supernatant. Data is presented as percentage of total release observed by lysis of liposomes by addition of detergent. Error
bars represent standard error of the mean (n=3) and asterisks indicate statistical significance calculated by one way Anova (p*,0.05). Data is
representative of multiple independent experiments.
doi:10.1371/journal.ppat.1004294.g004
Figure 5. VP4 forms a multimeric complex. A. VP4His was incubated in the presence of the membrane-mimetic detergent DHPC or liposomes,
or mock-treated (2), resolved by native PAGE and visualised by silver staining. The position of bands shown by arrows indicates potential migration
of VP4His into the gel. B. VP4 was incubated with (+) or without (2) liposomes and crosslinked by the addition of DSP at 0.5 mM (+) or 1 mM (++).
Samples were resolved by non-reducing SDS-PAGE and detected by western blot using antisera to VP4. DTT was used in some samples to reverse the
crosslinking prior to SDS-PAGE. Arrows indicate VP4 multimers. Molecular mass markers (in kilodaltons) are indicated on the left.
doi:10.1371/journal.ppat.1004294.g005
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conditions of SDS-PAGE, reinforcing the case for this structure
as a biologically relevant assembly. VP4His multimerization was
also detectable in the absence of membranes (Fig. 5B, lanes 1–4),
suggesting that multimerization may be an intrinsic property of the
protein which is membrane-independent. Alternatively, the
detergent used in preparation for SDS-PAGE may have provided
a micellar environment which promoted multimerization. VP4
multimerization was not observed after disrupting virus with SDS
in preparation for SDS-PAGE (see Fig. 1), however, the amount of
VP4 in virus-derived samples was relatively low such that
multimers may be more difficult to detect.
VP4 multimeric structure visualized by electron
microscopy
To facilitate detection of multimeric VP4 complexes by electron
microscopy, we used recombinant VP4 fused to a larger tag, the
26 kDa glutathione S-transferase (VP4GST). This protein was
previously shown to be functional for interaction with and
induction of permeability in model membranes [18]. In the study
reported here, myristoylated VP4GST was mixed with the
membrane mimetic zwitterionic detergent dodecylphosphocholine
(DPC), protein-micelle complexes were purified by size exclusion
chromatography and examined by negative stain transmission
electron microscopy. Ring-like structures were readily observed
(Fig. 6a and 6b) consistent with ‘top-down’ views of multimeric
pores. We also initially tried to image VP4 in liposomes but in our
hands the negative stain images were of poor quality while
reconstitution of VP4 in detergent gave far superior results. We
therefore took forward the latter strategy to generate the data
shown in the manuscript. An image data set representing all
detected structures (n=5929) was separated into seven class
averages (Fig. 6c). Several different classification schemes were
tested with varying numbers of classes, and a K-means classifica-
tion with seven classes gave the most consistent and interpretable
classes. We believe the overall micelle-pore complexes (VP4GST+
micelle) would in fact be wider than they are high, therefore
forming an overall disc shape which would preferentially lie flat on
the grid perhaps favouring orientation of the pore facing upwards
and reducing the number of alternate views. Of the seven classes,
two were selected (class 3 and 7 in Fig. 6c) as clear top-down views
(the remainder appeared to represent mis-alignments or side views
of the complex) and analysed by rotational harmonic analysis
which indicated 5- or 6-fold symmetry (Fig. 6d), consistent with a
pentameric or hexameric complex of VP4GST molecules. The
initial appearance of the class 3 average as a complex with 3-fold
symmetry may be due to the propensity of the GST fusion partner
to form dimers, thus initially presenting six GST moieties as three
dimers. However, the appearance of the class 7 average as a
pentameric structure suggested that GST dimerization was not
controlling the stoichiometry of the complex. It is conceivable that
recombinant VP4 is able to form pore structures with different
numbers of multimers; perhaps a single preferred structure for the
native virus-derived pore may be influenced by additional factors.
VP4-induced membrane permeability is comparable to
that of virus
We wished to confirm that the function of recombinant VP4
was relevant to the membrane interactions of virus particles.
Previous studies demonstrated that PV was able to induce
electrical conductance channels in planar model membranes
[19,28]. We therefore compared the membrane permeability
induced by VP4His and purified HRV16, by measuring CF
leakage from liposomes in the dye-release assay. Recombinant
VP4 and purified virus induced membrane permeability with
broadly similar characteristics (Fig. 7). However, virus-induced
permeability was more efficient at 37uC than at 25uC, while the
recombinant VP4-induced permeability was relatively unaffected
by the change in temperature. These observations demonstrate a
temperature dependence for HRV-membrane interactions, con-
sistent with previous studies with PV [19] and with a model of
temperature dependent particle breathing which controls the
exposure and membrane interactions of internal capsid compo-
nents such as VP4 [29,30]. Although studies with PV demon-
strated breathing only at physiological temperatures approaching
37uC [29], studies with HRV have shown particle breathing at
lower temperatures such as 25uC [30]. Importantly, virus samples
pre-treated at 60uC to convert virions into empty particles induced
only low levels of permeability, most likely because empty particles
would no longer contain VP4.
The membrane permeability induced by recombinant VP4 was
enhanced at low pH (Fig. 3). We therefore investigated the effect
of pH on virus-induced permeability by comparing the perme-
ability induced by virus at pH 6.5 (representing early endosomes)
and pH 5.5 (representing late endosomes) (Fig. 8). This demon-
strated that virus-induced permeability was significantly enhanced
at pH 5.5, consistent with this lower pH contributing to the
triggering of particle alterations involved in membrane interac-
tions and uncoating. In addition, we carried out dextran release
studies to investigate if virus-induced permeability was size-
selective, as shown earlier for recombinant VP4 (Fig. 4). Virus-
induced permeability was indeed also size-selective, with the
smaller dextrans being released to a significantly greater extent
than the larger dextran (Fig. 9). This confirmed that virus-induced
permeability was not via the large scale disruption of the
membrane but was also likely to involve a defined pore. However,
while the results for the VP4 pore suggested limiting the transfer of
molecules with Stokes’ radius approaching ,60 A ˚, the virus-
induced permeability permitted partial release of these molecules,
appearing to have a larger size cut-off, perhaps consistent with the
involvement of additional capsid components in the virus-induced
pore such as the N-terminus of VP1.
Discussion
Previous studies have demonstrated that during picornavirus
cell entry, the internal capsid protein VP4 is released from the
virus and interacts with cell membranes. Furthermore, it has been
shown that mutations in VP4 alter both the ability of the virus to
induce permeability in model membranes and to deliver the viral
genome into the cell [14]. In the present study we have
characterised the ability of recombinant HRV VP4 to induce
permeability in model membranes and demonstrated that VP4
forms a multimeric, size-selective membrane pore, with dimen-
sions consistent with the transport of viral RNA.
Native VP4 is myristoylated at its N-terminus. This modification
is often a feature of proteins with membrane binding properties
[31,32]. Existing mutagenesis studies have implicated VP4 as
important for the formation of pores in electrophysiology
experiments and for RNA release [14], and the addition of the
N-terminal nine amino acids (including myristoylation signal) of
PV VP4 to GFP was previously shown to target the fusion protein
to membranes [33]. Myristoylation of VP4 has been shown to be
essential for the assembly of infectious virions, unfortunately
making it difficult to further probe the role of myristoylation of
VP4 in pore formation in the context of the intact virus. Although
myristoylation was not essential for the formation of functional
Picornavirus VP4 Forms a Membrane Pore
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improves pore formation and probably acts by increasing the
efficiency of initial membrane interaction.
Conditions of low pH appeared to favour both VP4 and virus
induced permeability, increasing the extent and rate of perme-
ability, suggesting that membrane activity may be optimised for
the low pH conditions encountered in acidified endosomes, the site
of membrane penetration by HRV. Permeability was greater at
pH 5.5 (the pH of late endosomes) relative to pH 6.5 (the pH of
early endosomes) which is in contrast to the early endosome as the
site of uncoating of the major group HRV14 [21]. The site of
uncoating for HRV16 (from which the recombinant VP4 was
derived) has not been determined. However, HRV16 interacts less
efficiently than HRV14 with the major group receptor ICAM-1
[34] and requires a lower pH to trigger uncoating in vitro [35],
suggesting that uncoating of HRV16 could indeed involve a
Figure 6. VP4 multimeric structure visualized by electron microscopy. A. VP4GST was reconstituted in the membrane mimetic detergent
DPC, applied to carbon coated grids and stained with uranyl formate. Scale bar=20 nm. B. Individual ring-like structures were manually selected and
cropped from unprocessed digital images. Scale bar=10 nm. C. Class average images of particles automatically picked from a large image data set
and classified into 7 classes. Scale bar=5 nm. D. Class averages 3 and 7 (top-down views) analyzed by rotational harmonic analysis.
doi:10.1371/journal.ppat.1004294.g006
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consistent with our data for optimal membrane permeability at
pH 5.5. The effect of low pH was most pronounced for
myristoylated VP4, again suggesting that myristoylation is
required for maximal activity. In these studies, low pH may act
to promote VP4-membrane interaction, multimerization, solubil-
ity or pore stability. However, not all picornaviruses penetrate the
membrane from within acidified vesicles and the increase in pore
forming ability at lower pH seen with HRV16 VP4 may not apply
universally across the virus family.
The permeability induced by recombinant VP4 was size-
selective, such that dextrans of 4 and 10 kDa were released from
liposomes efficiently, relative to larger dextrans of 70 and
250 kDa. Permeability induced by virus was also size-selective
but allowed partial release of the intermediate size dextrans (10
and 70 kDa), perhaps suggesting virus derived pores are larger,
consistent with the potential involvement of additional capsid
components such as the N-terminus of VP1. Together this strongly
suggested that release of dextrans was via a pore in the membrane
and that permeability did not involve large scale membrane
disruption or lysis of liposomes. This confirmed an earlier study in
which liposomes permeabilized by recombinant VP4 remained
intact [18] and is consistent with ion channel formation by PV
[28], the size-selective release of dextrans from endosomes during
infection of cells by the minor group HRV2 [17] and the transfer
of genome into intact liposomes by both HRV2 [36] and PV
(unpublished data). An alternative model for major group HRV14
membrane penetration has been proposed to involve endosome
disruption instead of pore formation reviewed in [11]. Although
our current findings with recombinant VP4 of HRV16 are not
consistent with membrane disruption, both models may be
possible due to subtle differences between viruses in terms of pH
sensitivities, involvement of receptor and proportion of VP4
released.
Figure 7. VP4-induced permeability is comparable to that of virus. Carboxyfluorescein-containing liposomes were mixed with VP4His at
5 mM (equivalent to approximately 5 mg/assay) or 1 mg HRV16 (equivalent to 50 ng VP4/assay) and membrane permeability detected by fluorescence
measurements recorded every 30 seconds. Assays were conducted at 25uC( A)o r3 7 uC( B). Only a minority proportion of recombinant protein is
thought to take part in the reaction. Data is presented as % of total end-point release observed by lysis of liposomes by addition of detergent. Data
shown is representative of multiple experiments (n.3).
doi:10.1371/journal.ppat.1004294.g007
Figure 8. HRV-induced membrane permeability is enhanced by low pH. A) Carboxyfluorescein (CF)-containing liposomes at pH 6.5 and
pH 5.5 were mixed with HRV (0.5 mg) and membrane permeability resulting in leakage and dequenching of CF was detected by fluorescence
measurements (excitation 492 nm/emission 512 nm) recorded every 30 seconds (as in figure 3). B) End points of HRV induced membrane
permeability. Data in panels A and B was normalized to the maximum signal induced by melittin at each pH value. Data shown is representative of
multiple independent experiments (n.3). Error bars represent standard error of the mean (n=3) and asterisks indicate statistical significance
calculated by one way Anova (p*,0.05).
doi:10.1371/journal.ppat.1004294.g008
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mixing with liposomes or detergent (Fig. 4), suggesting that VP4
was altered, or formed a complex, with the micellar environment
provided by these reagents. Based on the majority of evidence
indicating a model of pore formation by picornaviruses, we
hypothesised that VP4 permeability probably involved formation
of a discrete pore structure, which for a protein the size of VP4,
would only be possible by formation of a multimeric complex.
Chemical cross-linking and SDS-PAGE confirmed the ability of
recombinant VP4 to multimerize and suggested the formation of a
stable hexameric complex. VP4 complexes visualised by TEM
confirmed the formation of a multimeric pore and harmonic
analysis suggested a pentameric or hexameric structure. For many
years the picornavirus virion was predicted to interact with the
membrane and release its RNA at a capsid vertex at the 5-fold
symmetry axis. Furthermore, receptor binding was shown to align
the PV particle with a five-fold axis of symmetry pointing towards
the membrane [37]. It was therefore tempting to speculate that 5
copies of externalised VP4 would simultaneously insert into the
membrane and form a pentameric complex. However, both PV
and HRV2 are thought to disengage with their receptors before
membrane penetration occurs, so that an alternative alignment
with the membrane (away from the 5-fold) was also possible. In
recent years it has become clear that indeed neither the site of
RNA release or site of externalisation of capsid components is at
the five-fold axis [38–41]. A recent study has visualized PV linked
to liposome membranes by a long connector or umbilicus during
the act of RNA translocation [16]. The virus is tilted away from
the 5-fold to expose the quasi-3-fold axis (the site of externalisation
of VP1) to the membrane. The connector is likely to contain
capsid protein VP1 (the capsid footprint of the connector coincides
with the VP1 exit site). How the putative multimeric complex
formed by recombinant VP4 is related to this structure is
unknown, perhaps the VP4 structure provides the membrane
pore, while the externalised VP1 molecules provide the connector.
Chemical crosslinking revealed that VP4 forms a multimeric
complex even in the absence of membranes, this could be evidence
that VP4 multimerizes prior to membrane insertion. This
possibility is supported by a previous study which demonstrated
that two copies of VP4 could be cross-linked together on the
surface of HRV particles during the transient externalisation of
capsid components that occurs in particle ‘breathing’ [42]. In the
current study VP4 dimers were also observed as the predominant
form of multimer. In an alternative model where membranes are
required for VP4 multimerization, it is possible that detergent
micelles encountered in preparation for SDS-PAGE were able to
provide a membrane-like environment which promoted VP4
multimerization. Although perhaps counter-intuitive that such a
multimer would survive boiling in SDS, similar highly stable
multimers have been reported for other small hydrophobic viral
pore forming proteins such as the hepatitis C virus p7 protein [43].
The release of fluorescent dyes from liposomes by recombinant
VP4His appeared to share similarities to that induced by virus.
The comparison of directly equivalent amounts of VP4His and
virus particles was difficult due to the expectation that the very
hydrophobic nature of VP4His would cause it to have low
solubility when diluted into the assay, making it likely that only a
minor proportion of the recombinant protein would take part in
the membrane interaction. However, we speculated that if the
active proportion of VP4His was only 1% of the total (5 mg), this
would be equivalent to 50 ng of active VP4His per assay,
approximately equivalent to the amount of native VP4 provided
by 1 mg of virus. Virus induced permeability was more temper-
ature sensitive, but this could be entirely consistent with virus-
membrane interactions and induction of permeability being
related to particle ‘breathing’ which are increased at physiological
temperatures. The similarities between the VP4- and virus–
induced permeability could be interpreted as suggesting that VP4
is solely responsible for membrane permeability during virus entry.
However, the finding that virus-induced permeability allowed
release of larger dextran molecules relative to VP4His, suggests
that the virus-derived pore might be larger, consistent with the
potential involvement of additional capsid components in the pore,
such as the N-terminus of VP1.
The size-selective pore formed by recombinant VP4, which
permits transfer of dextrans of 4 kDa (Stokes’ radius of 14 A ˚) and
10 kDa (Stokes’ radius of 23 A ˚) but restricts dextrans of 70 kDa
(Stokes’ radius of 60 A ˚) or above would suggest a pore with lumen
diameter of between approximately 4.6 nm and 12 nm. Multi-
meric VP4 pore complexes visualized by TEM were consistent
with this size. For the virus derived pore, which restricts the
passage of dextrans of 250 kD (Stokes’ radius of 105 A ˚) the lumen
diameter would be predicted to have an approximate dimension of
between 12 nm and 21 nm. These potential channel dimensions
can only be considered as approximate estimates. However, since
the potential role of the pore is transfer of the viral genome, we
were encouraged to consider the dimensions of existing channels
capable of transporting RNA. Structural models of cellular RNA
polymerases include an approximately 30 A ˚ long, 15 A ˚ wide
channel, known as the ‘‘RNA-exit-channel,’’ through which the
nascent single strand of RNA exits the polymerase [44,45]. Alpha-
hemolysin is a bacterial heptameric transmembrane pore through
which single stranded molecules of DNA or RNA can be driven by
an applied electric field. During this process, nucleotides can be
detected passing through the channel pore in sequential order due
to the limiting diameter of the pore, which at its narrowest point is
14 A ˚ in diameter [46]. Therefore a channel 14–15 A ˚ in diameter
could be considered the absolute minimal size required for active
transport of unstructured single stranded RNA. In the case of
Figure 9. HRV-induced permeability is size-selective. Liposomes
containing FITC-labelled dextrans of 4 kD (FD4), 10 kD (FD10), 70 kD
(FD70) or 250 kD (FD250) were mixed with 0.5 mg HRV or preheated
HRV. Release of dextrans was quantified by pelleting the liposomes and
measuring the fluorescence in the supernatant (as in figure 4). Data is
presented as percentage of total release observed by lysis of liposomes
by addition of detergent. Error bars represent standard error of the
mean (n=3) and asterisks indicate statistical significance calculated by
one way Anova (p*,0.05). Data is representative of three independent
experiments.
doi:10.1371/journal.ppat.1004294.g009
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involvement of a much larger pore, perhaps not surprising
considering both the lack of energy for active transport of a long
molecule through a constricted channel and the potential for
secondary structure in the genomic RNA.
In recent years, entry inhibitors have been developed that
prevent exposure, multimerization or membrane insertion of the
viral fusion proteins of enveloped viruses such as dengue virus and
HIV [47,48] and as reviewed in [49,50]. For picornaviruses, the
exposure, multimerization and membrane insertion of VP4
appears to be the equivalent process. The findings in this study
present the first direct evidence of multimerization and pore
formation by picornavirus VP4. This provides a novel molecular
mechanism for VP4-mediated membrane permeability during
picornavirus entry and suggests that VP4 be considered as an
antiviral target for this family of viruses.
Materials and Methods
Construction of VP4 expression plasmid
The sequence encoding HRV16 VP4 was amplified from
pET23d VP4GST [18] by PCR using primers VP4F (59-TAT-
ACCATGGGCGCTCAAGTATCTAGACAGAATG-39) and
VP4HisR (59-TATACTCGAGTCAATGGTGATGGTGAT-
GGTGTTGCAGAGTG-39). The resulting sequence encoded
VP4 with an additional six histidines at the C-terminus and
flanked by start and stop codons (indicated in bold) and restric-
tion sites (underlined). This DNA was cloned into pET23d
(Novagen) to create pETVP4His. Insert integrity was confirmed by
sequencing.
Expression and purification of recombinant VP4
Recombinant VP4 was expressed in E. coli (BL21 DE3 pLysS)
as myristoylated protein (VP4His) by co-transformation of bacteria
with pETVP4His and a plasmid encoding N-myristyltransferase
(pET-NMT), or as unmyristoylated protein (DVP4His) by
transformation with only pETVP4His. The myristoylation of
recombinant VP4 in this system was previously confirmed by mass
spectrometry [18]. Expression was induced by the addition of
0.2 mM isopropyl b-D-1-thiogalactopyranoside (IPTG). Myristic
acid was added to a final concentration of 5 mg/ml to cultures co-
transformed with pET-NMT. Bacteria were lysed in denaturing
lysis buffer (7M urea, 1% Triton X-100, 20 mM HEPES pH 7.5),
sonicated and the clarified supernatant applied to a pre-packed
nickel affinity column (GE Healthcare). Proteins were eluted with
increasing concentrations of imidazole and fractions analysed by
SDS-PAGE and Coomassie staining or western blot. Fractions
containing VP4 were pooled and dialysed sequentially against
decreasing concentrations of urea after which precipitated VP4His
was collected by centrifugation and resuspended in DMSO.
Recombinant myristoylated VP4 tagged with GST (VP4GST) was
similarly expressed using pET23d-VP4GST and pET-NMT [18]
and purified as described above for VP4His.
Purification of virus
HRV16 derived from an infectious cDNA plasmid [51] was
propagated in HeLa Ohio cells and purified using standard
methods [52]. Briefly, infected cell cultures were lysed by freeze/
thawing and clarified supernatants concentrated by precipitation
with ammonium sulphate. Virus particles were purified by
pelleting through a cushion of 20% (w/v) sucrose in PBS followed
by sedimentation in a sucrose density gradient comprising 15–45%
(w/v) sucrose in PBS. Purified virus was quantified by absorbance
at 260 nm, where an optical density of 7.7=1 mg/ml. For some
membrane permeability experiments virus was preheated at 60uC
for 10 min to convert native virus into empty particles.
Preparation of liposomes
Liposomes comprising of phosphatidic acid, phospatidylcholine,
cholesterol and rhodamine-labelled phosphatidylethanolamine
(Avanti Polar Lipids) (molar ratios 44.5:44.5:10:1 respectively)
were prepared as previously described [13] by rehydration of dried
lipid films in 107 mM NaCl, 10 mM Hepes pH 7.5 and extrusion
through 400 nm pore-size membranes using a mini-extruder
(Avanti Polar Lipids). The lipid concentration of liposome
preparations was estimated by comparing the level of rhodamine
fluorescence in the liposome sample relative to samples of
rehydrated lipids of known concentration. The expected diameter
(average 400 nm) and size distribution of liposomes was confirmed
by dynamic light scattering (Malvern Zetasizer mV). Liposomes
containing carboxy-fluorescein (CF) (Sigma) were prepared by
rehydrating lipids in the presence of 50 mM CF, 10 mM Hepes
pH 7.5. Liposomes containing FITC-conjugated dextrans (FD;
Sigma) were prepared by rehydrating lipids in the presence of
25 mg/ml FD, 107 mM NaCl, 10 mM Hepes pH 7.5. Liposomes
containing CF or FD were purified from external fluorescence by
multiple cycles of ultracentrifugation [18] and resuspended
in107 mM NaCl, 10 mM Hepes pH 7.5.
Membrane permeability assays
Membrane permeability was measured by detecting the release
of fluorescent material from within liposomes. Purified liposomes
containing CF or FD were added to test substances (recombinant
protein, peptide, virus or mock controls in typical volume 5 ml) to
give typical final concentrations of 50 mM lipid,107 mM NaCl,
10 mM HEPES pH 7.4 and total volume of 100 ml. Reagents and
plastic-ware were pre-equilibrated to the reaction temperature
(25uCo r3 7 uC).
For CF release, reactions were assembled in 96-well plates and
membrane permeability detected in real time by the release,
dequenching and increase in fluorescence of CF. Measurements
were recorded every 30 s for 1 hr using a fluorescence plate reader
with excitation and emission wavelengths of 485 nm and 520 nm
respectively (Plate CHAMELEON V, Hidex). Initial rates were
calculated from the linear slope of lines generated from the initial
four data points.
For FD release, permeability reactions were incubated for 1 hr,
liposomes pelleted at 100,0006g for 30 mins and fluorescent signal
in the supernatant measured using the plate reader as above. The
signal released by the addition of 0.5% (v/v) Triton X-100 was
taken as 100% and all supernatants were adjusted to 0.5% (v/v)
Triton X-100 prior to recording fluorescent measurements, to
normalise for fluorescence quenching by presence of detergent.
For experiments investigating the effect of pH on the induction
of membrane permeability, CF release reactions were assembled
with 10 mM sodium citrate/citric acid buffer at pH 5.5, 6.5 or 7.0
(instead of HEPES). CF fluorescence is quenched at low pH.
Experiments to confirm this were carried out by adjusting a stock
solution of CF (50 mM CF, 10 mM Hepes pH 7.5), to different
pH values by 100-fold dilution in the citrate/citric buffers
described above. After 1 hour, samples were re-adjusted to pH 8
by addition of small volumes of 1M NaOH. Fluorescence was
measured as described above. The quenching of CF fluorescence
at low pH clearly presented a problem for comparing real time
data at different pH values. Thus, real time CF release induced by
the pH independent pore forming peptide melittin appeared to be
reduced at low pH but the true signal in end point supernatants
were all revealed as equivalent values if adjusted to neutral pH.
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the endpoint value induced by melittin at that pH.
DSP cross-linking
VP4His was incubated in the presence or absence of liposomes
(50 mM lipid) at 25uC for 1 hr, before addition of the membrane
permeable cross-linker DSP (Thermo scientific) to final concen-
tration of 0.5 mM or 1 mM and incubation for a further 20 min at
25u. The reaction was terminated by the addition of 1 M Tris
pH 7.5. Samples were analysed by SDS-PAGE under non-
reducing conditions. If required, cross-linking was reversed by
the addition of 50 mM DTT and incubation at 37uC for 30 min.,
before analysis by SDS-PAGE.
Polyacrylamide gel electrophoresis (PAGE) and western
blot
For native PAGE, purified VP4His (5 mg) was vacuum dried
and rehydrated by shaking at 25uC in either liposomes (equivalent
to 50 mM lipid) in 107 mM NaCl, 10 mM HEPES pH 7.4, or
300 mM diheptanoyl-sn-glycero-3-phosphocholine (DHPC) in
20 mM HEPES pH 7.4. Samples were mixed with an equal
volume of 30% glycerol, 0.05% bromophenol blue, 150 mM Tris-
HCl pH 7.0, prior to native PAGE using a 4 to 20% gradient gel
(TGX, Bio-Rad). Samples were not heated prior to electropho-
resis. Protein was visualised by silver staining (Pierce). For SDS-
PAGE, samples were heated at 96uC for 10 min in 10% glycerol,
2% (w/v) SDS, 0.01% (w/v) phenol red, 62.5 mM Tris-HCl
pH 6.8 (@ 25uC). Proteins were separated using 12% or 16.5%
polyacrylamide gels and detected by staining with Coomassie
brilliant blue R-250 (Sigma) or by silver staining (Pierce).
Alternatively, proteins were transferred to polyvinyl difluoride
(PVDF) membrane and identified using anti-VP4 sera (raised
against a peptide corresponding to the C-terminus of VP4), a
peroxidase-conjugated secondary antibody (Sigma) and ECL
substrate (Thermo scientific).
Electron microscopy (EM)
EM grids bearing a carbon support were glow discharged for
15 s using an EMS 1006 (EMS). VP4GST was reconstituted in
DPC micelles by rehydrating in 100 mM DPC, 150 mM NaCl,
20 mM sodium acetate pH 5.5 and micelles containing VP4GST
were purified by size exclusion chromatography (Superose 6
1/300, GE Healthcare), adsorbed onto grids and stained using
0.75% uranyl formate. Images in Fig. 6A were collected on a
JEOL 1200EX operating at 80 kV. For large image data sets,
zero-loss filtered images were collected on a Zeiss Cs-TEM MC
Libra200 operating at 80 kV equipped with an in-column filter set
to 10 eV, and an Ultrascan 4000 CCD camera (Gatan).
Image processing
Particles were picked with a semi-automated algorithm imple-
mented in EMAN2 [53], e2boxer.py. All further processing was
done in SPARX [54]. The particles were aligned, and classified
using a K-means algorithm, which produced 7 classes. These
classes were then used as references in a multi-reference
alignment. To obtain an estimate of the rotation symmetry
present in each of the classes, each class average was rotated and
cross-correlated with the original for all angles ranging from 0 to
359 degrees in increments of 1 degree. The cross-correlation
coefficient was then plotted versus the rotation angle, and number
of peaks and peak separation inspected for likely n-fold symmetry.
Supporting Information
Figure S1 Migration of VP4His is not altered when
diluted in a constant concentration of DMSO. The
indicated amounts of VP4His were diluted in a standard volume
of DMSO, subjected to SDS-PAGE and visualized by silver
staining. Molecular mass markers (in kilodaltons) are indicated on
the left.
(TIF)
Figure S2 Carboxyfluorescein (CF) fluorescence is
quenched by low pH and detergent. A. CF-containing
samples were adjusted to pH 5.5, 6.5 or 7.0 and fluorescence
recorded, samples were re-adjusted to pH 8 (‘recovered’) and
fluorescence recorded again. B. CF released from liposomes by the
pH dependent peptide GALA (1 mM) or the pH independent
peptide melittin (10 mM), or by 0.5% (v/v) detergent TX-100.
(TIF)
Figure S3 Micrograph image of DPC micelles in the
absence of VP4. Prepared as described in materials and
methods except samples were not subjected to size exclusion
chromatography. The difference in appearance and contrast in
this figure (relative to figure 6) may therefore be due to a higher
sample concentration. Scale bar=20 nm.
(TIF)
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